Albemarle Corporation ALB

Albemarle Corporation es un desarrollador, fabricante y comercializador global de productos químicos especializados altamente ingenierizados. La compañía opera a través de tres segmentos: Litio, Especialidades de Bromo y Catalizadores. El segmento de Litio desarrolla materiales basados en litio para una amplia gama de industrias y mercados finales. Desarrolla y fabrica una amplia gama de compuestos básicos de litio, incluyendo carbonato de litio, hidróxido de litio, cloruro de litio y especialidades de litio de valor agregado y reactivos. El segmento de Especialidades de Bromo de la compañía se enfoca en el negocio de bromo y basado en bromo, que incluye productos utilizados en soluciones de seguridad contra incendios y otras aplicaciones de productos químicos especializados. El segmento de Catalizadores consta de tres líneas principales de productos: Tecnologías de Combustibles Limpios, que está compuesto principalmente por catalizadores de hidroprocesamiento (HPC) junto con catalizadores de isomerización y alquilación; catalizadores y aditivos de craqueo catalítico fluidizado (FCC); y soluciones de catalizadores de rendimiento (PCS).

Con 10 acciones de ALB (USD 1.051,35) habrías recibido USD 16,40 en dividendos en los últimos 12 meses.

ALB hizo una división de acciones (split) de 2:1 el 2 de marzo de 2007: cada acción se convirtió en 2. Cambió la cantidad de acciones y su precio, pero no el valor total de la inversión.

• Zacks Investment Research 30 sept

  Albemarle (ALB) Registers a Bigger Fall Than the Market: Important Facts to Note

  Albemarle (ALB) declined 1.71% to $105.78, underperforming the S&P 500's 0.25% loss. The specialty chemicals company has fallen 20.6% over the past month, significantly worse than its sector's 8.47% decline. Despite strong earnings forecasts showing 1442% EPS growth and 16% revenue growth for the upcoming quarter, ALB holds a Zacks Rank #4 (Sell) rating. The stock trades at a Forward P/E of 9.45, below its industry average of 15.9, with a PEG ratio of 0.63 suggesting undervaluation.

  

• Zacks Investment Research 30 sept

  Is Trending Stock Albemarle Corporation (ALB) a Buy Now?

  Albemarle (ALB) has declined 20.6% over the past month, significantly underperforming the S&P 500. While the company shows strong revenue growth (+18.7% projected for current fiscal year) and has consistently beaten earnings and revenue estimates, it received a Zacks Rank #4 (Sell) rating due to unchanged earnings estimate revisions. The stock trades at a valuation discount to peers but is expected to underperform the broader market in the near term.

  

• Zacks Investment Research 29 sept

  Albemarle vs. Rio Tinto: Which Lithium Stock Holds More Promise?

  Albemarle (ALB) and Rio Tinto (RIO) are both well-positioned to benefit from growing lithium demand driven by electric vehicles and energy storage. ALB is executing capacity expansion projects and achieving significant cost savings, while RIO is advancing major lithium projects with a stronger balance sheet. Rio Tinto appears to offer better value with more attractive valuation metrics, higher return on equity, and rising earnings estimates, making it the more favorable investment option currently.

  

• GlobeNewswire Inc. 28 sept

  Microporous Materials Market - Global Strategic Business Report: Secure your share of a $1.3B revenue expansion to $7.2B by 2030. BASF, Honeywell UOP, Albemarle and Evonik Accelerating the MOF andCarbon-Capture Race

  The global microporous materials market is projected to grow from $5.9 billion in 2024 to $7.2 billion by 2030, expanding at a 3.2% CAGR. Growth is driven by rising demand for carbon capture, clean fuels, purification, and advanced manufacturing applications. Key players including BASF, Honeywell UOP, Albemarle, and Evonik are accelerating development of metal-organic frameworks (MOFs) and carbon-capture technologies. Asia-Pacific, particularly China, is expected to see strong growth at 5.8% CAGR.

  

• Zacks Investment Research 21 sept

  Wall Street Bulls Look Optimistic About Albemarle (ALB): Should You Buy?

  While Wall Street analysts maintain a bullish stance on Albemarle (ALB) with an average brokerage recommendation of 1.87 (Strong Buy/Buy), the article cautions investors against relying solely on these recommendations. The Zacks Rank system assigns ALB a #4 (Sell) rating due to a 2.1% decline in consensus earnings estimates over the past month, suggesting analysts are becoming pessimistic about the company's earnings prospects.